Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 1, 2008The Neurologist

Clinical Comparisons of Botulinum Neurotoxin Formulations

View Full Paper
Ask AI
Bookmark
Share

Authors

ABAllison BrashearUniversity at Buffalo, State University of New York

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Allison Brashear (2008) studied this question.

synapsesocial.com/papers/6a2303dc6e4b7ecdd5f735f6https://doi.org/10.1097/nrl.0b013e31816f2cdd
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Botulinum toxin therapy, immunologic resistance, and problems with available materials1996 · 207 citations
  2. 2Botulinum toxin type B: A double-blind, placebo-controlled, safety and efficacy study in cervical dystonia1997 · 240 citations
  3. 3Synaptic Transmission: Inhibition of Neurotransmitter Release by Botulinum Toxins2003 · 247 citations
  4. 4Longitudinal experience with botulinum toxin injections for treatment of blepharospasm and cervical dystonia1993 · 115 citations
  5. 5Repeated Botulinum Toxin A Injections for the Treatment of Lines in the Upper Face2007 · 108 citations